January, 27 2014
Fabrizio Oleari, President of the Istituto Italiano di Sanità, meets the TITT Community
Milan, January 27th
How could Italy deal with the ongoing revolution in scientific research and innovation, in the field of health?
What are the current obstacles to the development of the new frontiers of medical research and innovation?
What role should play the Istituto Italiano di Sanità to encourage the development of research and innovation in healthcare in Italy?
These are the open topics for the meeting of the TITT Community with Fabrizio Oleari, President of the Istituto Italiano di Sanità, Monday January 27th, in Milan.
In all fields of life, research and innovation are the main important competitiveness boosters.
This is why the UE program Horizon 2020 – which aims to encourage research and innovation for growth and employment – is based on three fundamental pillars:
Even in health care, therefore, research and innovation assume an even more strategic role than in the past, beacuse of the framewowork, which is deeply changing both in demand for health and in health systems mode of response.
In particular, Italy have to reposition your own way of doing research, adapting it to ongoing changes in doctor-patient relationship: today it is all unbalanced on the first, while the patient should become the center of the entire healthcare system.
A good example in this regard, is the recent arrival on the medical scene of predictive medicine, which is the more personalized approach to health problems.
The predictive medicine, in fact, allows to determine the risk profile of each person, to monitor progresses and to make, where necessary, appropriate preventive measures as well as to select the therapy at the best time.
However, the predictive medicine requires a process of growth in knowledge and innovation, as well as in the cultural patterns. This process depends not only on the progress of research and innovation in healthcare, but even more on the ability to manage information.
In the predictive medicine revolution, more and more information will be available and we will be called to deal with them, particulary with genetic individual risk information.
We must be aware of the limitations and/or disadvantages of this new scientific opportunity.